CME Group Inc. $CME Shares Bought by TrueMark Investments LLC

TrueMark Investments LLC increased its stake in CME Group Inc. (NASDAQ:CME) by 3.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,909 shares of the financial services provider’s stock after purchasing an additional 993 shares during the period. CME Group accounts for about 1.6% of TrueMark Investments LLC’s portfolio, making the stock its 11th largest position. TrueMark Investments LLC’s holdings in CME Group were worth $7,417,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. GQG Partners LLC raised its position in CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after buying an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP raised its position in CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock worth $704,068,000 after buying an additional 2,089,935 shares during the last quarter. Nuveen LLC purchased a new position in CME Group during the 1st quarter worth approximately $218,842,000. Alliancebernstein L.P. raised its position in CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock worth $330,182,000 after buying an additional 808,740 shares during the last quarter. Finally, Egerton Capital UK LLP raised its position in CME Group by 79.4% during the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock worth $459,003,000 after buying an additional 765,773 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last quarter. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CME. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a research report on Thursday, October 9th. Barclays reduced their price target on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Morgan Stanley lifted their target price on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday, October 1st. Finally, Piper Sandler lifted their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $283.71.

CME Group Price Performance

NASDAQ:CME opened at $267.93 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $96.56 billion, a price-to-earnings ratio of 25.94, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41. The company has a 50 day moving average price of $267.30 and a 200-day moving average price of $271.38. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.56 EPS. Equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.